Andrea Matucci
Overview
Explore the profile of Andrea Matucci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
2006
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vivarelli E, Perlato M, Accinno M, Brugnoli B, Milanese M, Cataudella E, et al.
Respiration
. 2025 Mar;
:1-15.
PMID: 40064152
Introduction: Asthma is a heterogeneous chronic inflammatory disease involving different underling pathogenetic mechanisms. We aimed to investigate the characteristics of patients with the diagnosis of asthma and primary antibody immunodeficiency...
2.
Pomari E, Malago S, Ferrari G, Romano G, Mori A, Matucci A, et al.
Viruses
. 2025 Feb;
17(2).
PMID: 40007009
In an epidemiologic investigation of Enterovirus (EV) infections in a Verona hospital, September 2022-September 2024, we detected EV-C105 in six pediatric patients with upper respiratory symptoms between March and May...
3.
Caldrer S, Accordini S, Donini A, Gianesini N, Matucci A, Mori A, et al.
Microorganisms
. 2025 Feb;
13(2).
PMID: 40005722
Methods: Fourteen patients with laboratory-confirmed mpox were tested at different time points after the symptom onset. An immunofluorescence assay was performed to evaluate the seroconversion kinetics of specific IgA, IgM,...
4.
Benralizumab: from tissue distribution to eosinophilic cytotoxicity up to potential immunoregulation
Vultaggio A, Bergantini L, Crimi C, Matucci A, Menzella F, Schroeder J, et al.
Expert Opin Biol Ther
. 2024 Dec;
25(2):175-185.
PMID: 39708290
Introduction: Benralizumab, a monoclonal IgG antibody, has emerged as a key therapeutic agent in severe asthma by specifically targeting eosinophils, pivotal cells that drive inflammation and tissue damage. Over the...
5.
Deiana M, Malago S, Mori A, Accordini S, Matucci A, Mantovani R, et al.
Viruses
. 2024 Oct;
16(10).
PMID: 39459919
On 27 May 2024, the Cuban Ministry of Health reported the first outbreak of Oropouche fever on the island. The etiologic agent, Oropouche virus (OROV), is a poorly understood arbovirus...
6.
Orlando P, Vivarelli E, Minzoni A, Licci G, Accinno M, Brugnoli B, et al.
Eur Arch Otorhinolaryngol
. 2024 Oct;
282(1):265-272.
PMID: 39404884
Purpose: Mepolizumab was recently approved for treating Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) unresponsive to standard treatment or recurring after endoscopic sinus surgery (ESS). To date, few studies have assessed...
7.
Pomari E, Matucci A, Accordini S, Mantovani R, Gianesini N, Mori A, et al.
Viruses
. 2024 Sep;
16(9).
PMID: 39339902
Background: Oropouche virus (OROV) is a segmented RNA virus belonging to the genus in the family . Herein, an in-house droplet digital PCR (ddPCR) assay was used for the detection...
8.
Castilletti C, Mori A, Pomari E, Matucci A, Martelli G, Curiale S, et al.
Lancet Infect Dis
. 2024 Aug;
24(10):e602-e603.
PMID: 39127059
No abstract available.
9.
Caminati M, Brussino L, Carlucci M, Carlucci P, Carpagnano L, Caruso C, et al.
Cells
. 2024 Jul;
13(14.
PMID: 39056762
Hypereosinophilic syndrome (HES) encompasses a heterogeneous and complex group of different subtypes within the wider group of hypereosinophilic disorders. Despite increasing research interest, several unmet needs in terms of disease...
10.
Castilletti C, Mori A, Matucci A, Ronzoni N, Van Duffel L, Rossini G, et al.
Euro Surveill
. 2024 Jun;
29(26).
PMID: 38940002
Oropouche fever is caused by Oropouche virus (OROV), transmitted primarily through the bite of infected midges, particularly of the genus . The virus is mainly circulating in Central and South...